(JIVE) JPMorgan International - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46654Q7575

JIVE: Foreign Stocks, Developed Markets, Emerging Markets

JPMorgan International Value ETF (JIVE) is an exchange-traded fund that focuses on investing in equity securities and equity-related instruments of foreign companies, including subsidiaries of U.S. companies operating abroad. The funds investment scope encompasses both developed and emerging markets, providing a diversified portfolio that spans across various global economies. Developed markets include countries such as Australia, Canada, Japan, and those in Western Europe, while emerging markets cover a broader range of countries with growth potential.

The funds investment strategy is centered around value investing, targeting companies that are undervalued relative to their intrinsic worth. This approach is designed to capitalize on opportunities in the international market where stock prices may not fully reflect the companies true value. By investing in foreign large value companies, JIVE offers investors exposure to established businesses with strong fundamentals operating in diverse global markets.

Analyzing the technical data, JIVEs recent price action indicates a bullish trend, with the last price of $64.78 being at its 52-week high. The funds short-term (SMA20) and long-term (SMA50, SMA200) moving averages suggest a positive momentum, as the current price is above these averages. The Average True Range (ATR) of 1.05, or 1.63%, indicates moderate volatility. These technical indicators collectively suggest that JIVE is in an uptrend, with potential for further growth if the trend continues.

From a fundamental perspective, JIVEs Assets Under Management (AUM) stand at $353.52 million, indicating a reasonable size that can provide liquidity without being too capital-constrained. The funds focus on foreign large value companies positions it well to capitalize on value opportunities in international markets. Given the current global economic landscape, with potential for recovery and growth in various regions, JIVE is well-positioned to benefit from its diversified portfolio.

Forecasting JIVEs performance based on both technical and fundamental data, the outlook appears positive. Technically, the uptrend and positive momentum indicators suggest potential for further price appreciation. Fundamentally, the funds diversified exposure to international value companies and its reasonable AUM provide a solid foundation. Assuming the global economy continues on a path of recovery and growth, and value investing continues to attract investor interest, JIVE could see its price potentially reach $70 in the next 6-12 months, representing a 8% increase from its current price. This forecast is contingent on the funds ability to maintain its current investment strategy and on favorable market conditions.

Additional Sources for JIVE ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

JIVE ETF Overview

Market Cap in USD 415m
Category Foreign Large Value
TER 0.55%
IPO / Inception 2023-09-13

JIVE ETF Ratings

Growth Rating 55.5
Fundamental -
Dividend Rating 50.7
Rel. Strength 12.2
Analysts -
Fair Price Momentum 68.19 USD
Fair Price DCF -

JIVE Dividends

Dividend Yield 12m 2.21%
Yield on Cost 5y 2.91%
Annual Growth 5y 90.74%
Payout Consistency 100.0%
Payout Ratio %

JIVE Growth Ratios

Growth Correlation 3m 89.9%
Growth Correlation 12m 77.7%
Growth Correlation 5y 94.4%
CAGR 5y 21.92%
CAGR/Max DD 5y 1.59
Sharpe Ratio 12m 2.47
Alpha 14.85
Beta 0.656
Volatility 15.39%
Current Volume 13.1k
Average Volume 20d 28.6k
What is the price of JIVE shares?
As of June 21, 2025, the stock is trading at USD 66.77 with a total of 13,134 shares traded.
Over the past week, the price has changed by -1.08%, over one month by +0.98%, over three months by +6.41% and over the past year by +22.87%.
Is JPMorgan International a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, JPMorgan International (NASDAQ:JIVE) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.48 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JIVE is around 68.19 USD . This means that JIVE is currently overvalued and has a potential downside of 2.13%.
Is JIVE a buy, sell or hold?
JPMorgan International has no consensus analysts rating.
What are the forecasts for JIVE share price target?
According to our own proprietary Forecast Model, JIVE JPMorgan International will be worth about 75.6 in June 2026. The stock is currently trading at 66.77. This means that the stock has a potential upside of +13.28%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 75.6 13.3%